Yu-ting Xue
Fuzhou, 350005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
OTUB2/ALYREF axis modulates the docetaxel resistance of castration-resistant prostate cancer via upregulating ABCG4-mediated drug efflux.
Journal: International journal of biological sciences
Published: October 05, 2025
A feedback mechanism from prostate cancer cells to macrophages, reinforced by STAT1, regulates tumor progression and resistance to radiotherapy.
Journal: Cell death & disease
Published: June 26, 2025
Novel risk predictor of spontaneous rupture and hemorrhage of renal cell carcinoma based on clinical and radiographic characteristics.
Journal: World journal of urology
Published: June 07, 2025
Comprehensive Analysis Identifies Tumor Mutation Burden-associated Genes ASPM and KIF11 as Novel Biomarkers for Adrenocortical Carcinoma.
Journal: Current cancer drug targets
Published: March 04, 2025
Total or partial adrenalectomy for aldosterone-producing adenoma: can 68Ga-Pentixafor PET/CT predict surgical outcomes?
Journal: European journal of nuclear medicine and molecular imaging
Published: January 15, 2025
A comprehensive analysis-based study of Di-(2-ethylhexyl) phthalate (DEHP)-Environmental explanation of bladder cancer progression.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: September 17, 2024
Mechanical signal modulates prostate cancer immune escape by USP8-mediated ubiquitination-dependent degradation of PD-L1 and MHC-1.
Journal: Cell death & disease
Published: September 14, 2024
Molecular Subtypes Defined by Cuproptosis-Associated Genes, Prognostic Model Development, and Tumor Immune Microenvironment Characterization in Adrenocortical Carcinoma.
Journal: Journal of inflammation research
Published: April 22, 2024
Radiomics of Periprostatic Fat and Tumor Lesion Based on MRI Predicts the Pathological Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy.
Journal: Academic radiology
Published: March 17, 2024
Magnetic resonance imaging-based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer.
Journal: Cancer medicine
Published: February 01, 2024
Development and Validation of an MRI-Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients.
Journal: Cancer medicine
Published: January 06, 2024
Last Updated: 09/26/2026